Hemorragia uterina anormal y enfermedad de von Willebrand

Emmanuel Sánchez Díaz, María Camila Vélez Peláez, Laura Herrera Almanza, Mabel Dahiana Roldán Tabares, Yuban Sebastián Cuartas Agudelo, Lina María Martínez Sánchez

    Producción científica: Contribución a una revistaArtículo en revista científica indexadarevisión exhaustiva


    Introduction: Von Willebrand factor is a fundamental part of hemostasis, which interacts with platelets allowing interaction with the endothelium, which serves as a transporter and stabilizer of factor VIII. Objective: To dictate a therapeutic strategy for patients with von Willebrand disease. Methods: A literature search was carried out from January and March 2021 using the medical databases PubMed, SciELO, Medline and ScienceDirect and using the terms "abnormal uterine bleeding" and "von Willebrand disease". Articles in English and Spanish, published after 2015, were selected. Conclusions: Von Willebrand disease is a coagulopathy that can present itself in a wide spectrum of diseases, especially through clinical manifestations of bleeding. In the case of abnormal uterine bleeding, it affects the health and quality of life of patients, therefore, early diagnosis and timely comprehensive treatment is vital.

    Título traducido de la contribuciónAbnormal Uterine Bleeding and Von Willebrand Disease
    Idioma originalEspañol
    Número de artículoe860
    PublicaciónRevista Cubana de Obstetricia y Ginecologia
    EstadoPublicada - 19 jul. 2022

    Nota bibliográfica

    Publisher Copyright:
    © 2022, Editorial Ciencias Medicas. All rights reserved.

    Palabras clave

    • abnormal uterine bleeding
    • metrorrhagia
    • von Willebrand disease
    • von Willebrand factor

    Tipos de Productos Minciencias

    • Artículos de investigación con calidad Q4


    Profundice en los temas de investigación de 'Hemorragia uterina anormal y enfermedad de von Willebrand'. En conjunto forman una huella única.

    Citar esto